Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis: A Randomized Open-Label, Blinded-Endpoint Trial

NCT07852780 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07852780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Adjunctive Ursodeoxycholic Acid on Oxidative Stress, Inflammation, and Organ Dysfunction in Adults With Sepsis: A Randomized Open-Label, Blinded-Endpoint Trial
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2027
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis